The ZOCOR vs. LIPITOR Copyright 2006 Harvard Health Publications is now outdated with the release of ZOCOR released generic SIMIVASTATIN.
My question is "What do the clinical trials show for the differences between LIPITOR and ZOCOR?" My current understanding is that LIPITOR can have as much as a 30% higher success at preventing non-fatal heart attacks. This statistic (if true) would lead me to go with LIPITOR over ZOCOR / SIMIVASTATIN. Please provide some clinical research information that either confirms or denies this claim.
wow. that sounds so much like an advertisement.... Do you sell the stuff?
You are a complete ass for thinking this is of an add nature. I am very concerned about my health and have asked a very important question. If I knew the answer I wouldn't ask. The real problem is the amount of misinformation on the internet and because of an existing war between Pfizer and Merck for drug supremacy; the current information superficially available is slanted and not trust worthy. Someone needs to put their neck on the line and answer the question with empirical data. As of right now it's all about money and I personally would like to get the best health care possible. Somebody help here... Thanks!